Vimarsana
Biggest News Aggregation in the World

Page 29 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

Your Wrist Could Give Clues to Future Health - Vimarsana News

Your Wrist Could Give Clues to Future Health

MONDAY, Sept. 25, 2023 (HealthDay News) -- One day, it may be possible to monitor people for risk of disease through continuously measuring skin temperature.

Beactica Therapeutics announces collaboration with the National Center for Advancing Translational Sciences - Vimarsana News

Beactica Therapeutics announces collaboration with the National Center for Advancing Translational Sciences

/PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision oncology company, today announced that it has entered into a research collaboration agreement...

How Genome Sequencing Can Broaden the Scope of Newborn Screening - Vimarsana News

How Genome Sequencing Can Broaden the Scope of Newborn Screening

Standard newborn screening can detect dozens of inherited diseases, but genomics technology enables testing for hundreds of them. A North Carolina program evaluating the feasibility of bringing genomics to newborn screening is expanding with an initial goal of testing 5,000 babies in the next year.

Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins - Vimarsana News

Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins

A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial. The placebo-controlled study, part of the global clinical trials consortium known as Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE), will enroll approximately 1,500 people at research sites around the world.A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial. The placebo-controlled study, part of ...

Early convalescent plasma treatment may lower long COVID risk, study finds - Vimarsana News

Early convalescent plasma treatment may lower long COVID risk, study finds

Plasma from recovered patients, helpful in preventing severe COVID, could also decrease likelihood of post-COVID symptoms

Source: jhu.edu